Biblio

Found 106 results

Filters: Author is others [Clear All Filters]

2016

S. M. Hill, Heiser, L. M., Cokelaer, T., Unger, M., Nesser, N. K., Carlin, D. E., Zhang, Y., Sokolov, A., Paull, E. O., Wong, C. K., and , “Inferring causal molecular networks: empirical assessment through a community-based effort”, Nature methods, vol. 13, p. 310, 2016.

L. R. Roberts, Farshidfar, F., Zheng, S., Gingras, M. - C., Newton, Y., Shih, J., A Robertson, G., Hinoue, T., Hoadley, K. A., Gibbs, R., and , “Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles”, in HEPATOLOGY, 2016, vol. 64, p. 227A–227A.

T. T. Liu, Achrol, A. S., Mitchell, L. A., Rodriguez, S. A., Feroze, A., Iv, M., Kim, C., Chaudhary, N., Gevaert, O., Stuart, J. M., and , “Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment”, Neuro-oncology, vol. 19, pp. 997–1007, 2016.

J. K. Lee, Phillips, J. W., Smith, B. A., Park, J. Wook, Stoyanova, T., McCaffrey, E. F., Baertsch, R., Sokolov, A., Meyerowitz, J. G., Mathis, C., and , “N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells”, Cancer cell, vol. 29, pp. 536–547, 2016.

J. M. Drake, Paull, E. O., Graham, N. A., Lee, J. K., Smith, B. A., Stoyanova, T., Faltermeier, C. M., Carlin, D. E., Vashisht, A., Huang, J., and , “Patient-specific druggable networks in lethal prostate cancer through proteome-guided multi-omic integration”. American Association for Cancer Research, 2016.

R. Raj Aggarwal, Youngren, J., Sokolov, A., Huang, J., Thomas, G. V., True, L. D., Foye, A., Alumkal, J. J., Ryan, C. J., Beer, T. M., and , “Persistence of AR signaling in small cell neuroendocrine prostate cancer (SCNC) and intermediate atypical carcinoma (IAC): Results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).”. American Society of Clinical Oncology, 2016.

J. M. Drake, Paull, E. O., Graham, N. A., Lee, J. K., Smith, B. A., Titz, B., Stoyanova, T., Faltermeier, C. M., Uzunangelov, V., Carlin, D. E., and , “Phosphoproteome integration reveals patient-specific networks in prostate cancer”, Cell, vol. 166, pp. 1041–1054, 2016.

H. Si, Lu, H., Yang, X., Mattox, A., Jang, M., Bian, Y., Sano, E., Viadiu, H., Yan, B., Yau, C., and , “TNF-$\alpha$ modulates genome-wide redistribution of $Δ$Np63$\alpha$/TAp73 and NF-$ąppa$B cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer”, Oncogene, vol. 35, p. 5781, 2016.

R. Aggarwal, Beer, T. M., Gleave, M., Stuart, J. M., Rettig, M., Evans, C. P., Youngren, J., Alumkal, J. J., Huang, J., Thomas, G., and , “Targeting Adaptive Pathways in Metastatic Treatment-Resistant Prostate Cancer: Update on the Stand Up 2 Cancer/Prostate Cancer Foundation–Supported West Coast Prostate Cancer Dream Team”, European urology focus, vol. 2, pp. 469–471, 2016.

2015

R. Raj Aggarwal, Thomas, G., Youngren, J., Foye, A., Olson, S., Paris, P., Beer, T. M., Ryan, C. J., Witte, O., Evans, C. P., and , “Androgen receptor (AR) amplification in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) and enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WC”. American Society of Clinical Oncology, 2015.

E. Jay Small, Huang, J., Youngren, J., Sokolov, A., Aggarwal, R. Raj, Thomas, G., True, L. D., Zhang, L., Foye, A., Alumkal, J. J., and , “Characterization of neuroendocrine prostate cancer (NEPC) in patients with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) or enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer ”. American Society of Clinical Oncology, 2015.

A. D. Ewing, Houlahan, K. E., Hu, Y., Ellrott, K., Caloian, C., Yamaguchi, T. N., J Bare, C., P'ng, C., Waggott, D., Sabelnykova, V. Y., and , “Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection”, Nature methods, vol. 12, p. 623, 2015.

R. Akbani, Akdemir, K. C., B Aksoy, A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., J Auman, T., Ayala, B., and , “Genomic classification of cutaneous melanoma”, Cell, vol. 161, pp. 1681–1696, 2015.

J. Woodward, King, C., Coleman, D., Lisac, R., Schwartzman, J., Wang, N., Gleave, M., Gray, J., Thomas, G., Beer, T. M., and , “Integrative genomic analysis to identify emergent enzalutamide resistance mechanisms in castration-resistant prostate cancer”. American Association for Cancer Research, 2015.

B. Paten, Diekhans, M., Druker, B. J., Friend, S., Guinney, J., Gassner, N., Guttman, M., W Kent, J., Mantey, P., Margolin, A. A., and , “The NIH BD2K center for big data in translational genomics”, Journal of the American Medical Informatics Association, vol. 22, pp. 1143–1147, 2015.

J. N. Weinstein, Kim, J., Creighton, C. J., Akbani, R., Hoadley, K. A., Kim, W. Y., Morgan, M. B., Hinoue, T., Cherniack, A., Su, X., and , “Progress in The Cancer Genome Atlas bladder cancer project”. American Association for Cancer Research, 2015.

A. Abeshouse, Ahn, J., Akbani, R., Ally, A., Amin, S., Andry, C. D., Annala, M., Aprikian, A., Armenia, J., Arora, A., and , “The molecular taxonomy of primary prostate cancer”, Cell, vol. 163, pp. 1011–1025, 2015.

2014

E. Jay Small, Youngren, J., Thomas, G., Olson, S., Toschi, A., Foye, A., Alumkal, J. J., Rettig, M., Gleave, M. Edwin, Evans, C. P., and , “Androgen receptor (AR) amplification in patients with metastatic castration-resistant prostate cancer (mCRPC) refractory to therapy with abiraterone acetate or enzalutamide: Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team ”. American Society of Clinical Oncology, 2014.

Y. Yuan, Van Allen, E. M., Omberg, L., Wagle, N., Amin-Mansour, A., Sokolov, A., Byers, L. A., Xu, Y., Hess, K. R., Diao, L., and , “Assessing the clinical utility of cancer genomic and proteomic data across tumor types”, Nature biotechnology, vol. 32, p. 644, 2014.

M. Parfenov, Pedamallu, C. Sekhar, Gehlenborg, N., Freeman, S. S., Danilova, L., Bristow, C. A., Lee, S., Hadjipanayis, A. G., Ivanova, E. V., Wilkerson, M. D., and , “Characterization of HPV and host genome interactions in primary head and neck cancers”, Proceedings of the National Academy of Sciences, vol. 111, pp. 15544–15549, 2014.

J. N. Weinstein, Kim, J., Creighton, C. J., Akbani, R., Hoadley, K. A., Kim, W. Y., Morgan, M. B., Hinoue, T., Cherniack, A., Su, X., and , “Comprehensive characterization of urothelial bladder cancer: a TCGA Project update”. American Association for Cancer Research, 2014.

C. Genome Atl Network and , “Comprehensive molecular characterization of gastric adenocarcinoma”, Nature, vol. 513, p. 202, 2014.

C. Genome Atl Network and , “Comprehensive molecular characterization of urothelial bladder carcinoma”, Nature, vol. 507, p. 315, 2014.

C. Genome Atl Network and , “Comprehensive molecular profiling of lung adenocarcinoma”, Nature, vol. 511, p. 543, 2014.

E. Duhig, Clarke, B., Yang, I. A., Fong, K. M., Hunter, L., Windsor, M., Bowman, R. V., Network, C. Genome Atl, and , “Comprehensive molecular profiling of lung adenocarcinoma: the cancer genome atlas research network”, Nature, vol. 511, pp. 543–550, 2014.

Pages